The fact that AOD9604 doesnt bind to growth hormone receptors, and targets a precise pathway related to metabolic health, means its most interesting to researchers in the fields of obesity treatment and targeted fat burning, notably visceral fat and body composition improvements
Patience is the whole game
[] However, gastrointestinal side effects were dose-dependent, prompting further evaluation in ongoing global phase III trials to confirm its safety and efficacy in patients with obesity
Microfibrils, elastin fibres and collagen fibres in the human intervertebral disc and bovine tail disc
Some clinicians report smoother titration in patients using BPC-157 concurrently, though this hasn't been validated in controlled trials
Derived from epithalamin research, it has been investigated in models of telomere biology and pineal gland signaling